Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Lost Money on Moderna, Inc. (MRNA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
12:46pm, Monday, 16'th Sep 2024
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA) of a class action securities lawsuit.
Moderna, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
11:45am, Monday, 16'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 16, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
The Schall Law Firm Urges Investors With Losses In Moderna, Inc. To Join A Securities Fraud Case
11:00am, Monday, 16'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or
Class Action Filed Against Moderna, Inc. (MRNA) Seeking Recovery for Investors - Contact Levi & Korsinsky
10:30am, Monday, 16'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 16, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
Moderna's Recent Drop: 4 Reasons Bulls See Opportunity
09:42am, Monday, 16'th Sep 2024
Moderna Inc. NASDAQ: MRNA made headlines during the pandemic for its messenger ribonucleic acid (mRNA) technology used in its COVID-19 vaccine Spikevax. mRNA vaccines deliver a virus's blueprints or g
Levi & Korsinsky Notifies Shareholders of Moderna, Inc.(MRNA) of a Class Action Lawsuit and an Upcoming Deadline
08:45am, Monday, 16'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 16, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
08:30am, Monday, 16'th Sep 2024
LOS ANGELES , Sept. 16, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or "th
NEW YORK, NY / ACCESSWIRE / September 16, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
NEW YORK CITY, NY / ACCESSWIRE / September 16, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Modern
MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
05:45am, Monday, 16'th Sep 2024
NEW YORK , Sept. 16, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Moderna, Inc. (NASDAQ: MRNA).
Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
09:00pm, Sunday, 15'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 15, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
NEW YORK, NY / ACCESSWIRE / September 15, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
NEW YORK, NY / ACCESSWIRE / September 15, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Moderna, Inc. ("Moderna" or the "Company") (NASDAQ:MRNA) and certain officer
Moderna Inc Is Being Sued For Violating Securities Laws And Stakeholders Are Invited By The Schall Law Firm To Play A Part
11:00am, Sunday, 15'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
08:20am, Sunday, 15'th Sep 2024
Moderna was a huge pandemic name, but has struggled since the earlier days of the health crisis. The company is looking to introduce new products and then lower its R&D budget.
